Oncology programs and practices are continually challenged to keep pace with rapidly evolving clinical and technological advancements in the diagnosis, staging, and treatment of cancer. With approvals of new cancer drugs by the FDA each year and thousands of active clinical trials for cancer treatments in the U.S., the pipeline for new innovations is expanding. Incorporating the latest therapies and diagnostics into cancer programs can be difficult, particularly for lower-resourced community urban and rural practices, in which funding for training and new tools can be scarce.
To help facilitate education and training that new treatment options often require, ACCC has created the Oncology Practice Transformation and Integration Center (OPTIC). OPTIC has established a network of multidisciplinary professionals to support ongoing peer-to-peer learning and adoption of new therapies and technologies at community cancer centers.
OPTIC is guided by an expert steering committee representing the key disciplines involved in integrating new diagnostics, drug therapies, and guidelines. Some of OPTICs key deliverables include a three-part webinar series, a resource library, and an e-Learning activity. In the learning webinar series, “Building the Oncology Program of the Future,” experts discuss the intersection of organizational strategy, interpretation of data, and impact of quality improvement studies on health equity.
The OPTIC Resource Library provides relevant, useful information and tools on the adoption of new innovations and technologies for community cancer programs with a focus on operational issues. In addition, the OPTIC program is producing an interactive eLearning course that will support skill and knowledge building needed for healthcare teams to implement new innovations at their cancer program.
For more information on this project, please contact the ACCC Provider Education department.
Access a collection of quality improvement worksheets distributed during the pre-conference session hosted by OPTIC at ACCC’s 50th Annual Meeting & Cancer Center Business Summit, designed for implementation within your own setting:
In this 3-part learning webinar series experts discuss the intersection of organizational strategy, interpretation of data, and impact of quality improvement studies on health equity.
Gain the tools and knowledge needed to demonstrate the value of new initiatives, determine progress toward change, and measure return on investment (ROI). View the on-demand recordings of a 2-part virtual series now.
In support of the need for more advanced Digital Health Technologies, ACCC partnered with DiMe to create comprehensive resources that support the development of trustworthy CRS de-risking products.
By leveraging machine learning algorithms, natural language processing, and data analytics, AI accelerates the identification of potential drug candidates, optimizes preclinical and clinical testing, and reduces costs.
Despite substantial advances in screening, diagnosis, and treatment, notable disparities exist in oncology that often result in delayed diagnoses, suboptimal treatment, poor outcomes, and undertreatment of pain in certain racial and ethnic groups.
By leveraging modern health care technologies and data-driven insights, AI and machine learning have the potential to enhance screening, diagnosis, and personalized treatment strategies across multiple cancer types.
In an attempt to enhance patient access, comfort, and convenience while achieving institutional cost savings, the Froedtert & Medical College of Wisconsin Blood and Marrow Transplant and Cellular Therapy Program expanded its offerings by introducing autologous transplants as an outpatient service.
By thoughtfully and responsibly incorporating AI into our practices, we can enhance our ability to deliver care that is not only more personalized and effective but also deeply compassionate, across every type of cancer program.
This project is supported by AstraZeneca.
